| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 51.316 | 52 |
| GSM780708 | Untreated after 4 days (C2_1) | 43.7791 | 21 |
| GSM780709 | Untreated after 4 days (C3_1) | 43.8656 | 21 |
| GSM780719 | Untreated after 4 days (C1_2) | 41.1208 | 10 |
| GSM780720 | Untreated after 4 days (C2_2) | 45.0134 | 27 |
| GSM780721 | Untreated after 4 days (C3_2) | 43.353 | 19 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 42.2722 | 14 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 48.5685 | 43 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 38.2197 | 3 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 40.459 | 8 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 42.4488 | 15 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 46.1896 | 33 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 46.2305 | 33 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 46.0825 | 32 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 43.5244 | 20 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 45.8247 | 31 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 42.9864 | 17 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 44.9503 | 27 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 47.3112 | 38 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 45.6225 | 30 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 44.1892 | 23 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 45.1345 | 28 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 39.0089 | 4 |